Guinea Bissau Business Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guinea Bissau Business Update.

Press releases published on October 5, 2026

INNOVATE Completes Sale of DBM Global to IES Holdings
IES Holdings Completes Acquisition of DBM Global
SAIC Acquires Information Security Corporation, Expanding Zero-Trust, Post-Quantum Cryptography and Encryption Capability
DLH Wins $2 Million NIH Data Governance Pilot Task Order
ApolloMD Expands Support of Emergency Medicine Foundation with New Research Grant and Annual Contribution
Reliance Global Group Becomes Debt Free Following Retirement of 100% of Its Term Debt
Wood Mackenzie connects trusted energy intelligence with Microsoft Copilot
TeraWulf Expands Contracted Power Capacity at its Muskie Data Campus to 1 GW
Music Industry Community Brings Music, Networking, and Industry Connections to Chase Bell and LIRA’s “Do Me” Live Experience
AVEX Class Action Reminder: Robbins LLP Encourages AEVEX Corp. Investors to Contact the Firm for Information About Their Rights
Ohio's Cedarville University Opening New Florida Location
DEEP FISSION, INC. (NASDAQ: FISN) INVESTIGATION: Johnson Fistel Investigates Potential Securities Claims Following Short-Seller Report
Concentrix (NASDAQ: CNXC) Investor Alert: Johnson Fistel Investigates Following Revenue Outlook Cuts and $1.05 Billion Goodwill Impairment
Integra LifeSciences (NASDAQ: IART) Investor Alert: Johnson Fistel Investigates Following Flooding-Related Outlook Cuts and 21% Stock Decline
Noodle & Boo Introduces Drool Baby™: Finally, Comfort for the Drooliest Days
Coverys Reveals 68% of Inpatient Diagnostic Errors Occur on General Medical-Surgical Units
STMicroelectronics announces status of common share repurchase program
ASML reports transactions under its current share buyback program
Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing
Ensimmäinen potilas on saanut hoitoa Orion Pharman Faasi 1/2 -tutkimuksessa ODM-216-molekyylillä, joka on yhtiön ensimmäinen kliiniseen kehitysvaiheeseen edennyt biologinen syöpälääkeaihio

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Guinea Bissau Business Update

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.